Company ProfilePremium

AOM International Group Company Limited (formerly Kiu Hung International Holdings Limited)

Company Profile Analysis

Ticker: 0381.HK權識國際集團股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
AOM International Group Company Limited - Company showcase

Year Founded & Workforce

1981

378 Employees

AOM International Group Company Limited logo

AOM International Group Company Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AOM International Group Company Limited Overview

AOM International is a Hong Kong-listed, Bermuda-domiciled investment holding company with a portfolio of small consumer and agricultural businesses that have little in common with each other. About two-thirds of revenue comes from an OEM/licensed toys and gifts business that sells mainly to a few North American customers. The rest comes from a 51%-owned Hubei-based traditional Chinese medicine (TCM) herb and decoction-piece maker (Hubei Jincaotang) and a 60%-owned Fujian wine trading platform built around the heritage "Gushan" (鼓山) huangjiu (yellow rice wine) brand. Beneath these operating units sit loss-making associates: Jiangxi forestry land, a Samoa resort/casino development, Anhui yellow wine and Fujian tea. These associates have generated repeated share-of-loss and impairment charges. The group is loss-making (FY2025 attributable loss HK$121.7M), has net current liabilities, has defaulted on secured borrowings, and its auditor has flagged a going-concern material uncertainty. Its strategy since 2024 has been serial diversification into liquor, health food, medicinal-stew restaurants and digital-economy platforms, funded by repeated equity issuance.


Company's own description

The FY2025 results announcement describes the Company's principal activity as investment holding. It says the Group is principally engaged in four areas: (i) manufacturing and trading of toys and gifts items; (ii) development, processing and manufacturing of Chinese herbs products; (iii) investment in various businesses including fruit plantation, leisure and culture; and (iv) trading of wines, food and beverage products. Item (iv) was added in FY2024 after the Fujian Laojiu acquisition and widened in FY2025 to cover food and beverage.

Independent characterisation

In practice, AOM is a holding company with three revenue-generating businesses. Several equity-accounted associates and legacy investments sit alongside them; these produce no revenue and consume capital.

  1. Toys & gifts (65% of FY2025 revenue). This is a manufacturing and trading business whose largest customers are in North America. North America provided 63.2% of group revenue in FY2025. Cost of sales includes licence fees (HK$7.7M in FY2025) and royalty fees (HK$15.3M), so a meaningful part of the range is licensed product. The business depends heavily on a few customers: Customer A alone bought HK$79.6M (26.5% of group revenue) in FY2025. The US subsidiary reports in USD.

  2. Chinese herbs (18%). Hubei Jincaotang Pharmaceutical Co., Ltd. (湖北金草堂藥業有限公司), 51%-owned since 2021, makes TCM herbs and decoction pieces (飲片) in Mainland China. It is backward-integrating into its own herb plantation bases.

  3. Wines, food & beverage (17%). Fujian Laojiu Investment Co., Ltd., 60%-owned since 31 May 2024, trades wine (huangjiu) in Mainland China. In FY2025 this was briefly supplemented by commission income from food and beverage trading through Heilongjiang Yingli, which was acquired in Oct 2025 and sold in H1 2026.

Revenue model mix (FY2025)

Revenue modelFY2025 HKD Mn% of total
Manufacturing — toys and gifts122.640.8
Manufacturing — Chinese herbs products54.418.1
Trading — toys and gifts72.924.2
Trading — wines, food and beverage (incl. HK$3.3M commission)50.816.9
Total300.6100.0

All revenue is product revenue recognised at a point in time. There is no subscription, licensing-out or service revenue.

Value-chain position, customers and end-markets

BusinessValue-chain positionCustomer typeEnd-market
Toys & giftsContract/licensed manufacturer plus trading intermediaryLarge North American retailers/brand owners (concentrated); small UK sales began FY2025US/Canada consumer toys and gifts
Chinese herbsUpstream cultivation, processing and decoction-piece manufacturingHospitals, pharmacies, TCM distributors in PRC (inferred from the decoction business; customer types not itemised)PRC TCM pharmaceuticals
Wines/F&BBrand-owner/distributor of Fujian huangjiu; tradingDistributors, retail channels; 2026 plan for stew-pot restaurantsPRC alcoholic beverages / catering
AssociatesPassive minority holdings—PRC forestry/eco-tourism, Samoa resort, PRC tea, Anhui huangjiu

Strategy

Stated strategy (themes from filings)

Diversified investment strategy: Management repeatedly describes "exploring other investment opportunities that have earning potentials… to diversify its businesses and income base." The FY2025 MD&A explicitly ties the 2024 entry into wine trading to this strategy.

Vertical integration in TCM: Own herb plantation bases are presented as a 10-year plan for quality, cost control and supply security, aligned with PRC policy on optimising the TCM industry.

Liquor and health-food consumption: Positioning in huangjiu, health catering (stew pots, medicinal cuisine), premium cultural wine and cooking wine.

Digital economy and cross-border capital services (2026): Described by the board as consistent with "strengthening the core business and increasing shareholder value" and with diversifying risk.

Initiative register (last 24 months)

DateInitiativeDetailFinancial commitment
31 May 2024Wine trading entryFujian Laojiu Investment 60%—
24 Oct 2024Beijing wine HQOffice purchase RMB51.6MCancelled Jun 2025; deposit refunded
Nov–Dec 2024Rebrand to AOM InternationalName/stock short name change—
Jan 2025Sales-network expansion with IT firmSubsidiary cooperation with an IT company (per news feed)—
16 Jan 2025Medicinal-stew storesAgreement with Hunan Shilin Commercial Management—
22 Oct 2025F&B tradingHeilongjiang Yingli 65% for RMB6.5MReversed H1 2026 (sold for RMB3.0M)
17 Apr 2026Fujian Laojiu stew-pot storesSelf-operated plus franchise launch in 2026—
26 Jun 2026Cooking-wine distributionFujian Laojiu Sales 51% for HK$100M CBHK$100M CB at HK$0.16
27 Jul 2026Digital economy platformHainan Lianshang JV via Yuanmingtang (Guangzhou); 3-year agreement; Boao Global Digital Economy Conference co-host; "Samoa cross-border listing" servicesCapital injection amount not disclosed in media summary
6 Oct 2026Twelve Dynasties WinePremium aged huangjiu / cultural export—
OngoingTCM plantation basesPrepaid plantation contracts; HK$13.6M herbs capex FY2025HK$13.6M (FY2025 additions)
OngoingBalance-sheet repairRights issue / open offer / placing / CB under consideration; lender negotiationsNot quantified

ESG commitments, cost programmes and targets

ESG commitments: ESG reports for 2022, 2024 and 2025 were posted on 29 Jun 2026. No quantified targets were identified.

Cost programmes: None announced.

Medium-term targets/guidance: None publicly disclosed.

Products & Services

The company discloses very little product-level detail. The catalog below lists only what filings and announcements name; anything not named is marked as not disclosed.

Toys and gifts

OfferingDescriptionTarget customerLaunch/versionPricing modelNamed flagship
Manufactured toys and giftsIn-house/subcontracted manufacturing (HK$122.6M revenue FY2025). Licence fees (HK$7.7M) and royalties (HK$15.3M) indicate licensed IP productsNorth American retailers/brand owners; UK from FY2025—B2B unit pricing; 90-day credit terms (FY2023 disclosure)—
Traded toys and giftsSourced-and-resold product (HK$72.9M FY2025)Same—B2B—

Chinese herbs (Hubei Jincaotang)

OfferingDescriptionTarget customerNotes
TCM herb products / decoction pieces (飲片)Development, processing and manufacturing of Chinese herbs and the decoction business in Mainland ChinaPRC healthcare channel (not itemised)120-day credit terms (FY2023)
Herb plantation basesInfrastructure (including roads) built in 2023; 3–5-year contracts with local farming organisations (prepaid plantation costs HK$9.8M at end-2025); biological assets HK$5.8MInternal supplyManagement cites quality control, cost and supply security

Wines, food and beverage

OfferingDescriptionStatus
Fujian Laojiu wine tradingWine trading in Mainland China (HK$47.5M wine sales FY2025)Operating
"Gushan" (鼓山) huangjiu brandA Fujian rice-wine heritage claimed to date back about 200 years (Daxing winery, Daoguang era); trademark registered 1958 (per Apr 2026 announcement)Brand linked to the Fujian Laojiu group
Fujian Laojiu stew-pot (燉罐) restaurantsSelf-operated plus franchise health-cuisine stores using Gushan wine; positioned for health-oriented cateringAnnounced 17 Apr 2026 for launch in 2026
Medicinal-stew stores (Hunan Shilin cooperation)Development of medicinal cuisine stew storesAgreement 16 Jan 2025; results not disclosed
"Twelve Dynasties Wine" (十二朝代酒)Premium aged huangjiu in handmade Jingdezhen porcelain bottles with artwork by landscape painter Chen Chunyong; marketed as a cultural export productAnnounced 6 Oct 2026
F&B commission trading (Heilongjiang Yingli)Commission income HK$3.3M (FY2025)Disposed in H1 2026 for RMB3.0M (gain about HK$2.4M)
Cooking-wine distribution (Fujian Laojiu Sales, 51%)Cooking-wine (料酒) distributor; intended to integrate sales network and gain pricing controlPending major transaction (Jun 2026)

Non-revenue holdings

HoldingDescription
Multijoy Group (40%)Forestry concession, Nanfeng County, Jiangxi (1,765.53 mu); converting to an ecological sightseeing farm
USO Management & Holding (Samoa)Joint development of leased land for residential, luxury hotel/casino and villas; construction start delayed to Oct 2026 (previously Jan 2025)
Fujian Yuguo (tea)Tea associate; share of loss about HK$15K in FY2025
Anhui Fu Lao (20%)Huangjiu producer; ownership enforcement litigation ongoing
Outbound tourismNo turnover since at least FY2022
Inner Mongolia coal explorationFully written down
Culture (ceramics)Dormant

Financial Narrative

Sources: FY2025 and FY2024 come from the FY2025 Annual Results Announcement. FY2023 and FY2022 come from the FY2023 Annual Results Announcement.

Income statement: notes and sources

Notes: FY2021 cost of sales is derived (revenue minus GP). FY2021 operating income, EBITDA and D&A are aggregator values; the aggregator's FY2021 EBITDA (-57.6) is not reconcilable with its operating income and D&A, so treat FY2021 as indicative only. Zeros in FY2021 rows mean "not available," not literal zero. Aggregator operating income for FY2022–FY2025 differs from the derived figures above because of different classification. One data feed (Express News) reported FY2024 attributable net income as HKD -17.2M, but the audited figure is HK$-84.6M. Another (Moomoo/Zhitong) rendered FY2023 attributable profit as "HK$372.13 million"; the audited figure is HK$37.2M. The filed figures above prevail.

Key FY2023 and FY2025 non-operating items

FY2023's reported profit was not an operating profit. A HK$92.0M gain from writing off time-barred promissory notes and a HK$28.4M gain on loan capitalisation more than explain the HK$69.1M pre-tax profit. Excluding them, FY2023 would have shown a pre-tax loss of about HK$51M.

Per-share data

The weighted share count rose more than eightfold from FY2022 to FY2025 even after three consolidations (5:1 in Jun 2022, 5:1 in Apr 2023, 2:1 in Jan 2024). This reflects heavy dilution from placings, CB conversions and loan capitalisations.

Margins (%; derived)

Revenue CAGR: FY2021 to FY2025 is -1.8% a year. FY2020 to FY2025 is about +8.1% a year, using aggregator FY2020 revenue of HK$203.4M; most of that growth came from the Hubei Jincaotang acquisition in 2021. FY2022 to FY2025 is -10.6% a year.

Balance sheet

The company's gearing ratio uses a broad net-debt definition that includes trade payables, accruals and other payables, divided by total equity. At 30 Jun 2026 (interim, per media), cash was about HK$110.0M, borrowings about HK$235.4M, gearing 67.9% and net current liabilities about HK$7.6M.

Default disclosure (FY2025): Secured other borrowings of HK$63.9M plus accrued interest of HK$37.9M were in default. About HK$37.5M owed to a shareholder became subject to a written undertaking not to demand repayment before 31 Mar 2027.

Cash flow

The full consolidated cash-flow statements were not contained in the results announcements reviewed. Operating cash flow, capex and free cash flow are therefore not publicly disclosed in the sources reviewed; refer to the full annual reports. Available proxies:

The rise in cash in FY2024 and FY2025 should not be read as operating cash generation. FY2024 benefited from the HK$51.3M placing. FY2025 benefited from the refund of the RMB45M (about HK$49.0M) Beijing property deposit, while borrowings rose by about HK$60M.

Ratios (derived)

ROIC row: not computed (zeros = not meaningful) because NOPAT is negative or distorted in most years and tax and invested-capital definitions are unclear.

Commentary on trends and inflections

Revenue. Revenue peaked in FY2022 at HK$420.9M, the first full-year consolidation of Hubei Jincaotang. It has since fallen 28.6%. The FY2024 Fujian Laojiu acquisition (HK$51.6M) only masked organic decline: excluding wines, FY2024 revenue was HK$335.0M, down 12.7%. FY2025's 22.3% drop was broad-based. North American toy demand fell by HK$48.8M and Chinese herbs by HK$40.9M.

Profitability. Gross margin peaked at 43.2% in FY2023 on a richer herbs mix and has normalised to about 36%. The structural problem is overhead. Administrative expenses of HK$86.3M in FY2025 equal 28.7% of revenue, against 18.7% in FY2022, and staff costs in admin rose to HK$45.0M from HK$37.7M. Operating income turned negative in FY2025 for the first time since FY2021.

Below the line. Every year carries large associate losses (HK$46.4M in FY2025), finance costs (HK$31.8M) and recurring losses from issuing shares to creditors at below-market prices (HK$15.6M in FY2025, HK$17.2M in FY2024).

Balance sheet. Headline net debt has fallen from HK$270.6M (FY2022) to HK$100.7M (FY2025). This came from equity issuance and write-offs, not cash generation. The quality of liquidity has worsened: 97% of borrowings are current, a secured loan is in default, and net current liabilities persisted into mid-2026.

Working capital. Inventory days rose to 193 in FY2025, partly reflecting wine/F&B stock and slower toy turnover. Payables days stretched to 94, consistent with liquidity pressure.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsRevenue-generating?

Exploration

Minority interest in exploration rights of Bayanhushuo Coal Field and Guerbanhada Coal Mine, Inner Mongolia (about 500.05Mt JORC resources); held at FVTOCI and fully written down in FY2020

No

Toys and gifts items

Manufacturing and trading of toys and gifts

Yes

Fruit plantation

Associates: Multijoy Group (40%; 1,765.53 mu forest land, Nanfeng County, Jiangxi) and USO Management & Holding (Samoa; resort/villa/casino development)

No (share of results)

Leisure

Associates in PRC outbound tourism, tea (Fujian Yuguo) and wine (Anhui Fu Lao, 20%)

No (share of results)

Culture

Trading of ceramic items

No revenue in FY2022–FY2025

Chinese herbs

Hubei Jincaotang (51%): development, processing, manufacturing of Chinese herbs

Yes

Wines, food and beverage products

Fujian Laojiu (60%) wine trading; Heilongjiang Yingli F&B commission trading (Oct 2025 to H1 2026)

Yes

Segment revenue (HKD Mn)

Segment revenue (HKD Mn)FY2022FY2023FY2024FY2025

Toys and gifts items

293.0262.4239.7195.4

Chinese herbs

127.9121.595.354.4

Wines, food and beverage

0051.650.8

Total revenue

420.9383.9386.7300.6

Segment profit/(loss) (HKD Mn)

Segment profit/(loss) (HKD Mn)FY2022FY2023FY2024FY2025

Toys and gifts items

21.25.5-12.4-20.6

Chinese herbs

36.850.240.418.4

Wines, food and beverage

00-0.71.2

Fruit plantation

-16.4-31.8-33.9-40.0

Leisure

-18.2-45.4-3.1-6.4

Culture

00.600

Exploration

-0.05-0.0100

Total segment result

23.3-20.9-9.7-47.4

Segment margin (%)

Segment margin (%)FY2022FY2023FY2024FY2025

Toys and gifts items

7.22.1-5.2-10.6

Chinese herbs

28.841.342.433.8

Wines, food and beverage

00-1.42.4

Segment revenue growth (%)

Segment revenue growth (%)FY2023FY2024FY2025

Toys and gifts items

-10.5-8.6-18.5

Chinese herbs

-4.9-21.6-42.9

Wines, food and beverage

00-1.5

Group

-8.80.7-22.3

% of group revenue (%)

% of group revenue (%)FY2022FY2023FY2024

Toys and gifts items

69.668.362.0

Chinese herbs

30.431.724.6

Wines, food and beverage

0013.4

Toys gross margin (%)

Toys gross margin (%)FY2022FY2023FY2024FY2025

Toys and gifts GPM

35.537.137.735.9

Segment Overview (Half-Yearly)

SegmentH1 2026 revenue (HKD Mn)Segment result

Toys and gifts

75.5

Loss of about HK$8.68M

Chinese herbs

31.0—

Wines, food and beverage

62.7 (reported as down about 20.2%)

Profit of about HK$0.9M

Total

169.1 (vs 203.3 in H1 2025, -16.8%)

Attributable loss about HK$18.0M

“—” = not publicly disclosed.

Income Statement

Metric (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Revenue

323.7420.9383.9386.7300.6

Cost of sales

231.8263.9218.1245.0192.4

Gross profit

91.9157.0165.8141.7108.2

Selling and distribution costs

047.137.336.234.8

Administrative expenses

078.886.483.086.3

Operating income (GP less S&D less admin; derived)

-19.331.142.122.5-12.9

Depreciation and amortisation

29.134.515.717.516.6

EBITDA (derived)

-57.665.657.840.03.7

Finance costs

046.827.128.931.8

Share of results of associates

0-19.5-22.0-36.8-46.4

Pre-tax income

-219.5-29.469.1-65.8-103.4

Income tax expense

09.13.47.07.8

Profit/(loss) for the year

0-38.565.7-72.8-111.2

Net income attributable to owners

-226.8-59.537.2-84.6-121.7

Non-controlling interests

021.028.511.810.6

Balance Sheet

Item (HKD Mn)FY2022FY2023FY2024FY2025

Cancellation of time-barred promissory notes (gain)

092.000

Gain/(loss) on extinguishment of liabilities by share issue

028.4-17.2-15.6

Impairment of investment in associates

0-34.300

ECL impairment (net)

-0.4-27.5-9.01.9

Fair value gain on contingent consideration

12.35.000

Per share

Per shareFY2022FY2023FY2024FY2025

Basic/diluted EPS as reported (HK cents)

-58.7219.53-24.83-14.17

EPS adjusted for Jan-2024 2:1 consolidation (HK cents; derived)

-117.4439.06-24.83-14.17

Dividends per share (HK cents)

0000

Weighted avg shares (M, as reported)

101.4190.6340.9859.4

Margin (%)

Margin (%)FY2021FY2022FY2023FY2024FY2025

Gross margin

28.437.343.236.636.0

Operating margin

-6.07.411.05.8-4.3

EBITDA margin

-17.815.615.110.31.2

Net margin (attributable)

-70.1-14.19.7-21.9-40.5

Balance Sheet and Margin Analysis (%)

Metric (HKD Mn)FY2022FY2023FY2024FY2025

Total assets

879.9770.3796.6769.7

Property, plant and equipment

93.9107.899.7105.7

Investments in associates

310.3247.0204.9172.0

Goodwill

54.850.950.252.8

Other intangible assets

8.85.85.95.8

Goodwill and intangibles

63.656.756.158.6

Inventories

74.387.997.6101.6

Trade and bills receivables

57.357.257.441.6

Cash and equivalents

99.1111.9135.9156.2

Borrowings — current

101.8134.2143.1199.6

Borrowings — non-current

7.97.603.5

Convertible bonds (current plus non-current)

91.2130.698.046.8

Promissory notes

164.8000

Lease liabilities

3.92.66.27.1

Total debt incl. CBs, notes, leases (derived)

369.6275.0247.3256.9

Net debt (derived)

270.6163.1111.4100.7

Total liabilities

594.9430.3413.0433.4

Equity attributable to owners

185.7214.2249.2229.9

Non-controlling interests

99.3125.8134.5106.4

Total equity

285.0340.0383.6336.3

Net current assets/(liabilities)

-80.238.1-26.4-26.6

Company gearing ratio (%)

166.689.168.072.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash-flow proxy (HKD Mn)

Cash-flow proxy (HKD Mn)FY2022FY2023FY2024FY2025

Additions to segment non-current assets (capex proxy)

1.445.017.016.6

Dividends paid

0000

Share buybacks

0000

Net change in cash balance (derived)

012.824.020.3

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025

ROE (attributable, avg owners' equity; FY2022 on ending equity) (%)

-32.018.6-36.5-50.8

ROA (loss for year / avg total assets; FY2022 on ending) (%)

-4.48.0-9.3-14.2

ROIC

0000

Current ratio (x)

0.831.140.930.94

Debt/equity (total debt / total equity) (x)

1.300.810.640.76

Net debt/EBITDA (x)

4.12.82.827.2

Interest coverage (operating income / finance costs) (x)

0.661.550.78-0.41

Asset turnover (x)

0.480.470.490.38

DSO (days)

49.754.454.250.5

DIO (days)

102.8147.1145.4192.7

DPO (days)

20.837.040.893.7

Cash conversion cycle (days)

131.7164.5158.8149.5

Region revenue (HKD Mn)

Region revenue (HKD Mn)FY2022FY2023FY2024FY2025

North America (USA and Canada)

291.7261.8238.9190.0

PRC (including Hong Kong)

128.8122.1147.7105.8

Europe (FY2025: UK; FY2022: EU incl. UK)

0.2004.6

Others (Asia, South America, Mexico)

0.200.10.2

Total

420.9383.9386.7300.6

Region share of revenue (%)

Region share of revenue (%)FY2022FY2023FY2024FY2025

North America

69.368.261.863.2

PRC (incl. HK)

30.631.838.235.2

Europe

0.1001.5

Region growth (%)

Region growth (%)FY2023FY2024FY2025

North America

-10.3-8.7-20.5

PRC (incl. HK)

-5.221.0-28.4

Implied Mapping FY2025 Details

Implied mapping FY2025 (HKD Mn)North AmericaPRC (incl. HK)Europe/Other

Toys and gifts (195.4)

190.0

about 0.6 (residual)

4.8

Chinese herbs (54.4)

054.40

Wines, F&B (50.8)

050.80

Customers over 10% of revenue (HKD Mn)

Customers over 10% of revenue (HKD Mn)FY2022FY2023FY2024FY2025

Customer A (toys)

119.698.8123.279.6

Customer B (toys in FY2022–23; herbs in FY2024)

81.576.457.00

Customer C (herbs in FY2023; F&B in FY2024–25)

052.551.537.0

Customer D (toys, FY2024)

0050.70

Share of revenue from >10% customers (%)

48597338.8

Share Price & Returns

Reference pointApprox. price / indicator

Around Mar 2025

About HK$1.0 (market cap about HK$813M on about 789M shares; insider purchase at avg HK$0.99)

Jun 2025

Down about 66% YTD

21 Jul 2025

HK$0.53 market price at subscription completion

Mid-2026

About HK$0.084–0.10

1-year performance (Oct 2025 to Oct 2026)

Not precisely verified; estimated decline of 70–80%

3-year / 5-year

Not meaningful after three consolidations (2022, 2023, 2024). Aggregator shows annualised return since listing of about -22.8%

Valuation Multiples

MultipleAOMPeers

P/E (trailing)

Negative (aggregator about -0.9x)

Hang Seng toys sub-industry about 17–19x (aggregator)

P/B (on FY2025 owners' equity of HK$229.9M)

About 0.5x

Sub-industry about 4.6–5.1x (aggregator)

EV/Sales (EV = market cap about 115 plus net debt 100.7 plus NCI 106.4; derived)

About 1.07x (incl. NCI); about 0.72x (excl. NCI)

n/v

EV/EBITDA (FY2025 EBITDA HK$3.7M)

Over 50x (not meaningful)

n/v

Capital Markets

ItemStatus

Analyst consensus

No sell-side coverage identified

Dividend history

No dividends FY2022 to H1 2026; no stated dividend policy

Buyback authorisations

Standard AGM general mandate only; no repurchases in FY2024 or FY2025

Debt Maturity Profile

MaturityAmount

Due within 1 year (borrowings)

199.6

Due after 1 year (borrowings)

3.5

Convertible bonds (current)

46.8

Lease liabilities (current / non-current)

2.4 / 4.6

Issued shares (M)

Issued shares (M)FY2022FY2023FY2024FY2025

Shares in issue at year end

921.5193.5789.3947.1

Share Price & Returns by Date

DateInstrumentSizePriceUse

Aug 2022

Rights issue

691.1M shares; HK$139.4M net

HK$0.205

Debt settlement

Jun 2023

Loan capitalisation

9.21M shares

HK$0.298 market

HK$31.1M debt

Feb 2024

CB placing

HK$45M

Conversion HK$0.15

Capital base / business

May 2024

Loan capitalisation

19.35M shares

HK$0.147

HK$19.2M debt

Sep 2024

Placing

470M shares; HK$51.3M net

HK$0.111

Repay Hubei CB

Oct 2024

Loan capitalisation

53.2M shares

Market HK$0.78

HK$7.98M debt

Jul 2025

Subscription (set-off)

157.8M shares; HK$68M

HK$0.4309

Retire Second/Third Hubei CBs

Jul 2026

Specific-mandate share issue

About 236M shares (derived from share-count change)

—

Hubei CB loan capitalisation

Jun 2026 (pending)

Consideration CB

HK$100M

Conversion HK$0.16

Fujian Laojiu Sales 51%

Analyst Conclusions

Management guidance and consensus

Management provides no quantitative guidance. The stated outlook is to keep reviewing operations and exploring investments that diversify income, and to improve the financial position through three steps: settling or extending the defaulted loans, relying on the shareholder's repayment deferral to Mar 2027, and raising capital through a rights issue, open offer, placing or CB. There is no consensus estimate.

Bull case

  1. Herbs recovery. If plantation bases reach maturity and herb volumes recover toward FY2023 levels (HK$121.5M revenue, HK$50.2M segment profit), the group could return to segment-level profitability.

  2. Wine distribution consolidation. The Fujian Laojiu Sales acquisition could combine brand, distribution and pricing power around Gushan huangjiu. Combined with stew-pot franchising, it might build a coherent PRC consumer business that already broke even in FY2025 (segment profit HK$1.2M).

  3. Deep discount to book. At about 0.5x P/B against owners' equity of HK$229.9M, with HK$156.2M of year-end cash, successful restructuring of the defaulted debt could re-rate the shares. This depends on the associate carrying values (HK$172.0M) holding up.

Bear case

  1. Solvency. A loan default, net current liabilities, an auditor's going-concern flag and borrowings rising to about HK$235M by Jun 2026, with negative operating income, point to continued reliance on dilutive rescue financing.

  2. Core erosion. Toys revenue has fallen three years running (down 33% from FY2022) and has turned loss-making. It depends on a few US customers exposed to tariffs, and H1 2026 toys revenue was only HK$75.5M.

  3. Value leakage. Share issues to creditors below market (losses of HK$17.2M in FY2024 and HK$15.6M in FY2025), dilutive acquisitions (up to 625M new shares) and associate write-downs consistently transfer value away from minority shareholders.

Key catalysts and monitorables (next 12 months)

  • Outcome of negotiations on the defaulted HK$63.9M secured loan.

  • Any rights issue, open offer or placing: size, discount, and underwriter or controlling-shareholder support.

  • Completion and circular details of the Fujian Laojiu Sales 51% deal, including target financials and valuation support for HK$100M.

  • Capital commitment to and economics of the Hainan Lianshang / Yuanmingtang JV.

  • FY2026 annual results (due by end-Mar 2027) and the auditor's opinion.

  • US tariff developments affecting China-made toys, and the trend in North American orders.

  • Herbs revenue trajectory and the plantation-base ramp.

  • USO Samoa construction start (targeted Oct 2026).

  • Anhui Fu Lao enforcement ruling.

  • Board stability under the new Chairman, Fan Xuefei.

  • The 31 Mar 2027 expiry of the shareholder's repayment deferral (HK$37.5M).

Analyst verdict

AOM International is a distressed micro-cap holding company, not an operating growth story. Over FY2022–FY2025 it lost money in three of four years. Its single profitable year (FY2023) came entirely from writing off time-barred promissory notes and gains on loan capitalisation. Its genuine operating assets are a shrinking toy OEM with healthy gross margins but a heavy overhead load, a once-lucrative TCM herbs subsidiary whose revenue fell 43% in FY2025, and a sub-scale Fujian wine trading platform. Beneath these sit associates in Jiangxi forest land, Samoan resort land, tea and Anhui huangjiu. Over four years these have absorbed more than HK$125M of share-of-losses and impairments, and their HK$172M carrying value remains the largest single asset line.

The balance sheet is the binding constraint. The group ended FY2025 with net current liabilities, HK$101.7M of defaulted secured principal and interest, and an unmodified audit opinion carrying a going-concern material uncertainty, which the H1 2026 interim repeated. Management's answer has been the same for years: issue equity to creditors at a discount, consolidate shares, and announce new ventures. The ventures now span stew-pot restaurants, premium "cultural export" huangjiu, cooking-wine distribution paid for with a HK$100M CB worth up to half the existing share capital, and a digital-economy and Samoa-listing services platform. None has a disclosed earnings track record, and several earlier initiatives were reversed within months: the Beijing HQ purchase and the Heilongjiang Yingli acquisition.

The shares trade at roughly half of book value, but that discount reflects high governance risk, asset-quality doubts and ongoing dilution. A credible re-rating would require three things: a negotiated resolution of the loan default, an orderly and preferably pre-emptive capital raise, and a demonstrated turnaround in herbs or wine profitability. Until then, the evidence supports a high-risk, avoid/speculative-only stance.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedBackground (as disclosed)Status (Oct 2026)

Fan Xuefei (范雪飛)

Chairman, Executive Director

——

Chairman per 13 Aug 2026 notice

Li Lizhong (李立中)

Executive Director; Co-Chairman

4 Oct 2024

Age 49 (per biography); chairman of Lizhan Group; described as a blockchain/digital-currency scientist with over 100 patents (70+ blockchain); former senior role at Ant Financial; numerous academic and association titles

Serving; bought 14.2M shares at avg HK$0.99 (early 2025, per news feed)

Liu Mingqing (劉明卿)

Executive Director

27 Mar 2020

—

Serving

Yang Bincheng (楊斌成)

Executive Director

——

Serving

Tang Sing Hing, Kenny (鄧聲興)

Non-executive Director

——

Serving

Chak Ching Long (翟正龍)

INED; Audit Committee

——

Serving

Wang Xiao Ning (王曉寧)

INED; Audit Committee

——

Serving

Chen Yuxin (陳雨鑫)

INED; Audit Committee

13 May 2020

—

Serving

Yang Ling (楊鈴)

Former Chairman, ED

ED 5 Apr 2024; Chairman 4 Oct 2024

Age 40; Vice President of Fujian Laojiu Investment Group since 2021

No longer on board by 13 Aug 2026 (an executive director resignation was announced 15 Jul 2026; identity not confirmed from primary text)

Sun Weiwei (孫維維)

Former ED

5 Sep 2023

—

Resigned 24 Jun 2025 (personal commitments)

Zhang Qijun (張啟軍)

Former Chairman

——

Chairman as of Mar 2024; succeeded by Yang Ling Oct 2024

Wei Yu (魏鈺)

Former INED

19 Jun 2023

—

Replaced on Audit Committee by Chak Ching Long

“—” = not publicly disclosed.

Major Shareholders

HolderStakeNotes

Yang Zhu (vendor, Fujian Laojiu Sales)

Up to 625M conversion shares if CB converted

About 34.6% of the enlarged share capital on announcement basis

Feb 2024 CB placees

About 60.37% (as reported by news feed after conversion)

No fewer than six placees

Competitive Landscape

Competitors by Segment

SegmentCompetitorListingApprox. scaleRelative positioning vs AOM

Toys (OEM/licensed)

Dream International

HKEX 1126

Multi-billion HK$ revenue

Far larger OEM plush/plastic toy maker for global brands

Toys

Kader Holdings

HKEX 0180

Several hundred million HK$

Comparable heritage HK toy OEM

Toys

Playmates Holdings / Playmates Toys

HKEX 0635 / 0869

Hundreds of millions to billions HK$

Own-brand/licensed toys for the US market

Toys

Herald Holdings

HKEX 0114

Hundreds of millions HK$

Diversified HK toy/houseware maker

Toys

Pop Mart International

HKEX 9992

Tens of billions RMB

Designer-toy leader; different model, competes for licensed-IP shelf space

TCM herbs

China Traditional Chinese Medicine Holdings

HKEX 0570

Billions RMB

Leading TCM granule/decoction player

TCM herbs

Beijing Tong Ren Tang

SSE 600085 / HKEX 1666

Billions RMB

Premier TCM brand

TCM herbs

China Resources Sanjiu

SZSE 000999

Billions RMB

Scale TCM pharmaceutical

Huangjiu

Zhejiang Guyue Longshan Shaoxing Wine

SSE 600059

About RMB2bn

Category leader (Shaoxing)

Huangjiu

Kuaijishan Shaoxing Wine

SSE 601579

About RMB1–2bn

Major Shaoxing brand

Huangjiu

Shanghai Jinfeng Wine

SSE 600616

Hundreds of millions RMB

Shanghai-style huangjiu

Peer Comparison FY2025

MetricAOM (FY2025, verified)Dream IntlKaderGuyue Longshan

Revenue

HK$300.6M

Multi-billion HK$

Several hundred million HK$

About RMB2bn

Revenue growth

-22.3%

n/v

n/v

n/v

Gross margin

36.0%

n/v

n/v

n/v

Operating margin

-4.3% (derived)

n/v

n/v

n/v

R&D intensity

2.2%

n/v

n/v

n/v

Recent Developments

--

Company Snapshot

$38.6M

Revenue

378

Employees

1981

Founded

The Penthouse Level, Bermuda

Headquarters

SWOT Analysis

Strengths

  • Healthy toy gross margins. Toys GPM was 35.9% in FY2025, 37.7% in FY2024 and 37.1% in FY2023 (MD&A), resilient despite revenue declines.
  • Herbs segment historically highly profitable. Segment profit was HK$50.2M on HK$121.5M revenue in FY2023 (41.3% margin) and still HK$18.4M in FY2025.
  • Cash balance has risen. Bank balances and cash were HK$156.2M at end-2025, up from HK$99.1M at end-2022, though they fell to about HK$110M by Jun 2026.
  • Debt reduced from the FY2022 peak. Derived total debt fell from HK$369.6M (FY2022) to HK$256.9M (FY2025), and HK$164.8M of overdue promissory notes was eliminated in FY2023.
  • Legacy litigation largely cleared. The Guo dispute was settled on 3 Jul 2025, the Everbright claim was settled for about HK$149K in Aug 2024, and the HK$92M Eagle Praise notes were derecognised.
  • Shareholder support. A shareholder agreed not to demand HK$37.5M before 31 Mar 2027, and creditors repeatedly accepted shares in lieu of cash (2023, 2024, 2025, 2026).

Weaknesses

  • Persistent losses. Attributable losses were HK$59.5M (FY2022), HK$84.6M (FY2024) and HK$121.7M (FY2025). The only profitable year in the window (FY2023) relied on HK$120.4M of one-off gains.
  • Going-concern uncertainty. The auditor (KTC Partners) included a material uncertainty paragraph in FY2025, and it was repeated in the H1 2026 interim.
  • Loan default. Secured other borrowings of HK$63.9M plus HK$37.9M of accrued interest were in default at 31 Dec 2025.
  • Customer concentration. Customers above 10% accounted for 73% of FY2024 revenue, and a single customer bought HK$123.2M (31.9%).
  • Overhead burden. Administrative expenses reached 28.7% of FY2025 revenue (HK$86.3M), against 18.7% in FY2022.
  • Associate losses. Share of associates was HK$-46.4M in FY2025, HK$-36.8M in FY2024 and HK$-22.0M in FY2023, plus a HK$34.3M associate impairment in FY2023.
  • Governance. High board turnover, INED absence from AGMs in 2023 and 2025, a delayed FY2021 audit and ESG reports for three years filed on one day.

Opportunities

  • Cooking-wine distribution integration. The pending Fujian Laojiu Sales 51% deal could give pricing control and network economics, if it adds earnings.
  • Stew-pot franchise model. A capital-light franchise route into a fragmented category, as management describes it.
  • Herb plantation maturity. Plantation bases started in 2023 with a one-to-two-year ramp, which could restore herbs margins and volumes.
  • Market diversification in toys. First UK revenue of HK$4.6M in FY2025 could reduce US dependence.
  • Samoa land monetisation. USO construction is targeted for Oct 2026 and could crystallise value from an asset fully or largely impaired.
  • Anhui Fu Lao enforcement. The equity was frozen in Apr 2025; successful enforcement would secure a 20% huangjiu producer stake.

Threats

  • US tariff and trade policy. North America provided 63.2% of FY2025 revenue, and toys revenue fell 18.5% in FY2025 on lower North American demand.
  • Dilution. Up to 625M conversion shares from the HK$100M CB (about 52.8% of then-existing shares), on top of 157.8M shares (Jul 2025) and the Jul 2026 issue.
  • Refinancing risk. 97% of FY2025 borrowings were current (HK$199.6M of HK$203.0M), and H1 2026 borrowings rose to about HK$235.4M.
  • PRC consumption weakness. Management itself cites economic downturn and consumption downgrade (Apr 2026). Wines/F&B revenue fell about 20.2% in H1 2026.
  • Continued deterioration in herbs. Revenue fell 42.9% in FY2025, and H1 2026 herbs revenue was HK$31.0M.
  • Regulatory scrutiny. Repeated share issuances at a deep discount, large dilutive acquisitions and loss-making diversification may attract HKEX scrutiny of listing suitability (analyst risk assessment; no action disclosed).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
31 Mar 2025Board meeting to approve FY2024 resultsRoutine
31 Mar 2025FY2024 results: revenue HK$386.7M (+0.7%); attributable loss HK$84.6MReturn to loss after FY2023 one-offs
Apr 2025FY2024 Annual Report publishedFiling
23 Apr 2025PRC court freezes 20% Anhui Fu Lao equity held by Chen Jun WeiProgress in enforcement
Early 2025Co-Chairman Li Lizhong buys 14.2M shares at avg HK$0.99Insider buying near the share-price high
Jun 2025Shares down about 66% YTD (TipRanks)Severe de-rating
18 Jun 2025AGM (INEDs absent)Governance deviation
24 Jun 2025ED Sun Weiwei resignsBoard turnover
30 Jun 2025Beijing office purchase cancelled; RMB45M deposit refundedLiquidity relief; strategy reversal
3 Jul 2025Shareholder Ou Zhu settles Guo debt; Guo litigation resolvedRemoves a nine-year legacy dispute
4 Jul 2025Subscription agreement: 157.8M shares to offset Hubei CBsDeleveraging via dilution
22 Jul 2025Subscription completed (HK$0.4309; market HK$0.53); HK$15.6M extinguishment lossP&L hit
29 Aug 2025H1 2025: revenue HK$203.3M (+41.7%); attributable loss HK$6.0M vs profit HK$17.6MGrowth without profit
22 Oct 2025Heilongjiang Yingli 65% acquired (RMB6.5M)F&B expansion
31 Mar 2026FY2025 results: revenue HK$300.6M (-22.3%); loss HK$121.7M; going-concern uncertainty; secured loan default (HK$63.9M plus HK$37.9M interest)Material negative
31 Mar 2026Shareholder undertakes not to demand HK$37.5M before 31 Mar 2027Short-term liquidity support
17 Apr 2026Fujian Laojiu stew-pot store programme announced for 2026New retail concept
Apr 2026FY2025 Annual Report publishedFiling
16 Jun 2026AGM heldRoutine
17 Jun 2026Proposed issue of new shares under specific mandate for Hubei CB loan capitalisationFurther dilution
26 Jun 2026Major transaction: 51% of Fujian Laojiu Sales for HK$100M CB at HK$0.16 (up to 625M shares)Large potential dilution (about 52.8% of existing shares)
29 Jun 2026ESG Reports 2022, 2024 and 2025 published togetherSuggests late ESG compliance (analyst inference)
14 Jul 2026EGM approves subscription/specific mandate (164.3M votes, 100% for)Approval
15 Jul 2026Executive director resignation; board list updatedLeadership change
20 Jul 2026New shares issued under specific mandateShare count to about 1.18bn (aggregator)
27 Jul 2026Hainan Lianshang digital-economy cooperationPivot to digital/capital services
13 Aug 2026Board meeting notice (interim results 31 Aug 2026); Fan Xuefei named ChairmanConfirms chairman change
29 Sep 2026H1 2026: revenue HK$169.1M (-16.8%); attributable loss about HK$18.0M; LPS 1.68 cents; net current liabilities HK$7.6M; going-concern doubt; fund-raising under considerationResults published about a month after the scheduled board date (reason not disclosed)
H1 2026Heilongjiang Yingli sold for RMB3.0M (gain about HK$2.4M)Reversal of Oct 2025 deal
6 Oct 2026"Twelve Dynasties Wine" premium huangjiu project announcedBrand/premium push

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Revenue fell from HKD 323.7 Mn in FY2021 to HKD 300.6 Mn in FY2025.
AOM International Group Company Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue323.7420.9383.9386.7300.6
Cost of sales231.8263.9218.1245192.4
Gross profit91.9157165.8141.7108.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. AOM International Group — Annual Results Announcement FY2025 (31 Mar 2026) (www1.hkexnews.hk)
  2. Kiu Hung International Holdings — Annual Results Announcement FY2023 (28 Mar 2024) (www1.hkexnews.hk)
  3. AOM International — 2025 Interim Results Announcement (29 Aug 2025) (hkexnews.hk)
  4. AOM International — Notice of Board Meeting (13 Aug 2026) (www1.hkexnews.hk)
  5. AOM International — Resignation of ED Sun Weiwei (24 Jun 2025) (www1.hkexnews.hk)
  6. 10jqka/Caiwen — H1 2026 interim results summary (29 Sep 2026) (stock.10jqka.com.cn)
  7. 10jqka/Zhitong — Fujian Laojiu Sales 51% acquisition (26 Jun 2026) (stock.10jqka.com.cn)
  8. Gelonghui — Hainan Lianshang cooperation (27 Jul 2026) (m.gelonghui.com)
  9. Stockstar/Zhitong — Hainan Lianshang cooperation (wap.stockstar.com)
  10. Stockstar — EGM approval (14 Jul 2026) (wap.stockstar.com)
  11. Gelonghui — Twelve Dynasties Wine (6 Oct 2026) (m.gelonghui.com)
  12. Tiger/Zhitong — Stew-pot store programme (Apr 2026) (itiger.com)
  13. Tiger — FY2025 results summary (itiger.com)
  14. Tiger — FY2025 annual report summary (itiger.com)
  15. Tiger — H1 2025 results summary (itiger.com)
  16. ETNet — Announcements list (etnet.com.hk)
  17. ETNet — Fund-raising history (content.etnet.com.hk)
  18. Lixinger — Company data, director history and biographies (lixinger.com)
  19. Moomoo — News feed (name change, insider purchases, Hunan Shilin agreement) (moomooapp.com)
  20. TipRanks — Revenue and income statement history (FY2020–FY2021 aggregator data) (tipranks.com)
  21. MarketsMojo — ISIN and FY2025 summary (marketsmojo.com)
  22. cnyes — 2018 Anhui Fu Lao acquisition (news.cnyes.com)
  23. uSMART/AASTOCKS — 2019 chairman and CEO retirements (usmart.hk)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.